Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03079830Completed
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Cumulative postoperative dose of Piritramide at 48 hours. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03079830.